Use of Integrated SPECT/CT Imaging for Tumor Dosimetry in I-131 Radioimmunotherapy: A Pilot Patient Study

Documenti analoghi

• (131)I-Tositumomab Radioimmunotherapy: Initial Tumor Dose–Response Results Using 3-Dimensional Dosimetry Including Radiobiologic Modeling
  di: Dewaraja, Yuni K., et al.
  Pubblicazione: (2010)
• Accuracy of (131)I Tumor Quantification in Radioimmunotherapy Using SPECT Imaging with an Ultra-High-Energy Collimator: Monte Carlo Study
  di: Dewaraja, Yuni K., et al.
  Pubblicazione: (2000)
• Prediction of Therapy Tumor-Absorbed Dose Estimates in I-131 Radioimmunotherapy Using Tracer Data Via a Mixed-Model Fit to Time Activity
  di: Schipper, Matthew J., et al.
  Pubblicazione: (2012)
• Accurate Dosimetry in (131)I Radionuclide Therapy Using Patient-Specific, 3-Dimensional Methods for SPECT Reconstruction and Absorbed Dose Calculation
  di: Dewaraja, Yuni K., et al.
  Pubblicazione: (2005)
• Comparison of I-131 Radioimmunotherapy Tumor Dosimetry: Unit Density Sphere Model Versus Patient-Specific Monte Carlo Calculations
  di: Howard, David M., et al.
  Pubblicazione: (2011)